Secondary hyperlipoproteinaemia type 4 (Q106771): Difference between revisions

← Older edit

@@ Property / Canonical URI @@
+https://id.who.int/icd/entity/655730752
@@ Property / Canonical URI: https://id.who.int/icd/entity/655730752 / rank @@
+Normal rank
@@ Property / CURIE @@
+CID11:ID_655730752
@@ Property / CURIE: CID11:ID_655730752 / rank @@
+Normal rank
@@ Property / Canary Token @@
+dki-india-ID_655730752
@@ Property / Canary Token: dki-india-ID_655730752 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-16T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-16T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 16 August 2026 / rank @@
+Normal rank

Latest revision as of 13:46, 17 August 2026

This involves abnormally elevated levels of any or all lipids and/or lipoproteins in the blood. Type 4 is a secondary, autosomal dominant condition occurring in approximately 1% of the population.

Language	Label	Description	Also known as
default for all languages	ID_655730752
English	Secondary hyperlipoproteinaemia type 4	This involves abnormally elevated levels of any or all lipids and/or lipoproteins in the blood. Type 4 is a secondary, autosomal dominant condition occurring in approximately 1% of the population.